VOLITIONRX LTD — Director's Dealing 2016

Jun 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-06-16

Reporting Person: Reynolds Cameron John (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-16	Common Stock	X	4000	$3	Acquired	32897	Indirect
2016-06-16	Common Stock	J	3540	$3.39	Disposed	29357	Indirect
2016-06-16	Common Stock	X	12500	$2.5	Acquired	41857	Indirect
2016-06-16	Common Stock	J	9219	$3.39	Disposed	32638	Indirect
2016-06-16	Common Stock	X	12500	$3	Acquired	45138	Indirect
2016-06-16	Common Stock	J	11062	$3.39	Disposed	34076	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-16	Stock Option (Right to Buy)	$3	X	4000	Disposed	2016-11-25	Common Stock (4000)	Indirect
2016-06-16	Stock Option (Right to Buy)	$2.5	X	12500	Disposed	2019-02-18	Common Stock (12500)	Indirect
2016-06-16	Stock Option (Right to Buy)	$3	X	12500	Disposed	2020-02-18	Common Stock (12500)	Indirect

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such net exercise transaction.